The Entourage Effect in Mushrooms: Natural psilocybin may outperform synthetic A new study from the Hebrew University-Hadassah Medical Center has indicated that natural psilocybin extracts may demonstrate superior efficacy to synthetic psilocybin extracts. Recent...
Psychedelics in 2024: a year for investment Following several transformative milestones in psychedelics, coupled with a surge in biotech investment, 2024 is set to see a profound shift for the sector as investors turn their attention toward solutions in mental health....
UK advisory body issues rapid response on psychedelics for anxiety The UK’s independent Parliamentary Office of Science and Technology (POST) has issued a rapid response on psychedelic-assisted therapy for anxiety disorders. The response is intended to inform...
Supporting psychedelic therapy with digital interventions A new paper has described the development of a self-directed intervention that harnesses digital technologies for psychedelic preparation. Psychedelics cause considerable changes in consciousness, requiring...
Psilocybin therapy for end-of-life care supported by 79% of Canadians A new survey has revealed that over 79% of Canadians support psychedelic-assisted therapy for existential distress at the end of life. People facing a terminal diagnosis often experience significant...